Evidence map›Paper›PMID 19633294›Full record

ArticleThe Journal of biological chemistry2009

Repression of Ca2+/calmodulin-dependent protein kinase IV signaling accelerates retinoic acid-induced differentiation of human neuroblastoma cells.

David M Feliciano, Arthur M Edelman

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Integrative Transcriptomic and Proteomic Analysis RevealsAnimals : an open access journal from MDPI · 2025
    Article
  2. Review
  3. Article
  4. Associations BetweenFrontiers in oncology · 2021
    Article
  5. Complex roles of cAMP-PKA-CREB signaling in cancer.Experimental hematology & oncology · 2020
    Review
  6. Article
  7. Article
  8. Polymorphism rs7214723 in CAMKK1 and lung cancer risk in Chinese population.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

David M FelicianoDepartment of Pharmacology and Toxicology, State University of New York, Buffalo, New York 14214, USA.
Arthur M Edelman
University at Buffalo, State University of New York · US

Funding

Identification of In Vivo Targets of Protein KinasesR21NS050385 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI EDELMAN, ARTHUR M · 2004 to 2005
$382k
NINDS NIH HHS R21 NS050385NINDS NIH HHS R21NS050385
6 · The paper itself

Abstract

Neuroblastoma cells having stem cell-like qualities are widely employed models for the study of neural stem/progenitor cell proliferation and differentiation. We find that human BE(2)C neuroblastoma cells possess a signaling cascade initiated by Ca(2+) influx via voltage-dependent calcium channels and the N-methyl-D-aspartate (NMDA) receptor and culminating in nuclear calmodulin-dependent protein kinase IV (CaMKIV)-mediated phosphorylation and activation of the transcription factors Ca(2+)/cyclic AMP-response element-binding protein (CREB) and ATF1 (activating transcription factor-1). This pathway functions to maintain BE(2)C cells in an undifferentiated, proliferative state. Parallel to this Ca(2+)-dependent pathway is a hormone-responsive program by which retinoic acid (RA) initiates the differentiation of BE(2)C cells toward a neuronal lineage. This is evidenced by RA-dependent induction of the cell cycle inhibitor p21/Cip1 (Cdk-interacting protein 1) and cell cycle arrest, induction of the neuroblastic marker doublecortin and of the neuron-specific intermediate filament protein, peripherin, and by RA-stimulated extension of neuritic processes. During neuronal differentiation there is a complex antagonistic interplay between these two major signaling pathways. RA down-regulates expression of CaMKIV and one of its upstream activators, CaMKK1 (calmodulin-dependent protein kinase kinase 1). This is accompanied by RA-induced suppression of activating phosphorylation of CREB with a time course paralleling that of CaMKIV down-regulation. RA-induced repression of the Ca(2+)/calmodulin-dependent protein kinase kinase/CaMKIV/CREB pathway appears to be involved in regulating the timing of neuronal differentiation, as shown by the effect of RNA interference of CaMKIV to markedly accelerate RA-dependent up-regulation of p21/Cip1 and doublecortin expression and RA-promoted neurite outgrowth. RA-induced repression of the CaMKIV signaling pathway may represent an early event in retinoid-dependent neuronal differentiation.

Indexed as

Activating Transcription Factor 1Antineoplastic AgentsCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 4Cell CycleCell DifferentiationCell Line, TumorCell ProliferationCell SurvivalCyclic AMP Response Element-Binding ProteinCyclin-Dependent Kinase Inhibitor p21Doublecortin Domain ProteinsHumansImmunoblottingMicrotubule-Associated ProteinsNeuropeptidesActivating Transcription Factor 1Antineoplastic AgentsATF1 protein, humanCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 4CAMK4 protein, humanCDKN1A protein, humanCyclic AMP Response Element-Binding ProteinCyclin-Dependent Kinase Inhibitor p21Doublecortin Domain ProteinsMicrotubule-Associated ProteinsNeuropeptidesTretinoin

Identifiers

PMID19633294
PMCPMC2785335
OpenAlexW2008281482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.